المؤلفون: Beuselinck, B, Wolter, P, Karadimou, A, Elaidi, R, Dumez, Herlinde, Rogiers, Annick, Van Cann, T, Willems, L, Body, Jean-Jacques, Berkers, J, Van Poppel, H, Lerut, E, Debruyne, P, Paridaens, R, Schöffski, P

المصدر: British Journal of Cancer, 107 (10

مصطلحات موضوعية: Sciences bio-médicales et agricoles, Antineoplastic Combined Chemotherapy Protocols -- adverse effects -- therapeutic use, Bone Density Conservation Agents -- administration & dosage -- adverse effects, Bone Neoplasms -- drug therapy -- pathology -- secondary, Carcinoma, Renal Cell -- drug therapy -- pathology -- secondary, Diphosphonates -- administration & dosage -- adverse effects, Disease-Free Survival, Female, Humans, Indoles -- administration & dosage, Kidney Neoplasms -- drug therapy -- pathology, Male, Middle Aged, Neoplasm Metastasis, Niacinamide -- administration & dosage -- analogs & derivatives, Osteonecrosis -- chemically induced, Phenylurea Compounds -- administration & dosage, Prognosis, Protein Kinase Inhibitors -- administration & dosage, Protein-Tyrosine Kinases -- antagonists & inhibitors, Pyrroles -- administration & dosage, Retrospective Studies, Treatment Outcome, Bisphosphonates, Bone metastases, Osteonecrosis of the jaw, Outcome, Renal cell carcinoma, Targeted therapy

وصف الملف: 1 full-text file(s): application/pdf

العلاقة: uri/info:doi/10.1038/bjc.2012.385; uri/info:pii/bjc2012385; uri/info:pmid/23132391; uri/info:scp/84869225968; https://dipot.ulb.ac.be/dspace/bitstream/2013/143043/3/doi_126664.pdfTest; http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/143043Test

الإتاحة: http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/143043Test

المؤلفون: Pascal Wolter, Alexandra Karadimou, Jean-Jacques Body, Patrick Schöffski, H. Van Poppel, Ludo Willems, Benoit Beuselinck, Philip R. Debruyne, Annick Rogiers, T. van Cann, R. Elaidi, Robert Paridaens, Herlinde Dumez, Joost Berkers, Evelyne Lerut

المصدر: British Journal of Cancer
British Journal of Cancer, 107 (10

مصطلحات موضوعية: Male, Cancer Research, Pathology, Diphosphonates -- administration & dosage -- adverse effects, Indoles, Phenylurea Compounds -- administration & dosage, Antineoplastic Combined Chemotherapy Protocols -- adverse effects -- therapeutic use, Targeted therapy, bone metastases, Renal cell carcinoma, Antineoplastic Combined Chemotherapy Protocols, Bone Density Conservation Agents -- administration & dosage -- adverse effects, Bone Neoplasms -- drug therapy -- pathology -- secondary, Sunitinib, Neoplasm Metastasis, Indoles -- administration & dosage, Outcome, Bone Density Conservation Agents, Diphosphonates, Protein Kinase Inhibitors -- administration & dosage, Osteonecrosis, Bisphosphonates, Sciences bio-médicales et agricoles, Middle Aged, Protein-Tyrosine Kinases, Sorafenib, Prognosis, targeted therapy, Kidney Neoplasms, Treatment Outcome, Oncology, outcome, Female, Niacinamide -- administration & dosage -- analogs & derivatives, Tyrosine kinase, medicine.drug, Carcinoma, Renal Cell -- drug therapy -- pathology -- secondary, Niacinamide, medicine.medical_specialty, renal cell carcinoma, Bone Neoplasms, Osteonecrosis -- chemically induced, Disease-Free Survival, Kidney Neoplasms -- drug therapy -- pathology, Pyrroles -- administration & dosage, medicine, Carcinoma, Humans, Pyrroles, Carcinoma, Renal Cell, Protein Kinase Inhibitors, bisphosphonates, Retrospective Studies, Osteonecrosis of the jaw, business.industry, Protein-Tyrosine Kinases -- antagonists & inhibitors, Bone metastases, Phenylurea Compounds, medicine.disease, osteonecrosis of the jaw, Concomitant, Cancer research, Clinical Study, business

وصف الملف: 1 full-text file(s): application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdb22c4137af4f142fa2a48d0882b042Test
https://pubmed.ncbi.nlm.nih.gov/23132391Test